These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 14726976)

  • 21. Cytomegalovirus prophylaxis with ganciclovir in kidney transplant recipients receiving induction antilymphocyte antibodies.
    Said T; Nampoory MR; Johny KV; Pacsa AS; Mini Abraham P; Nair MP; Abdel-Haleem M; Samhan M; Al-Mousawi M
    Transplant Proc; 2004; 36(6):1847-9. PubMed ID: 15350495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytomegalovirus infection in renal transplant recipients.
    Carstens J; Andersen HK; Spencer E; Madsen M
    Transpl Infect Dis; 2006 Dec; 8(4):203-12. PubMed ID: 17116133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Demonstration of HHV-6 antigens in biopsies of kidney transplant recipients with cytomegalovirus infection.
    Helanterä I; Loginov R; Koskinen P; Lautenschlager I
    Transpl Int; 2008 Oct; 21(10):980-4. PubMed ID: 18564986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Late cytomegalovirus disease with atypical presentation in renal transplant patients: case reports.
    Boobes Y; Al Hakim M; Dastoor H; Bernieh B; Abdulkhalik S
    Transplant Proc; 2004; 36(6):1841-3. PubMed ID: 15350493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polyoma virus-associated nephropathy and concurrent cytomegalovirus infection in the kidney transplant recipients.
    Park SB; Kwak JH; Lee KT; Hwang EA; Han SY; Kim HT; Cho WH; Choi MS; Kim HC
    Transplant Proc; 2006 Sep; 38(7):2059-61. PubMed ID: 16979999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An assessment of interactions between hepatitis C virus and herpesvirus reactivation in liver transplant recipients using molecular surveillance.
    Humar A; Washburn K; Freeman R; Paya CV; Mouas H; Alecock E; Razonable RR;
    Liver Transpl; 2007 Oct; 13(10):1422-7. PubMed ID: 17902128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of serology assays and polymerase chain reaction for the monitoring of active cytomegalovirus infection in renal transplant recipients.
    Naumnik B; Małyszko J; Chyczewski L; Kovalchuk O; Małyszko J; Myśliwiec M
    Transplant Proc; 2007 Nov; 39(9):2748-50. PubMed ID: 18021976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytomegalovirus infection after allogeneic transplantation: comparison of cord blood with peripheral blood and marrow graft sources.
    Walker CM; van Burik JA; De For TE; Weisdorf DJ
    Biol Blood Marrow Transplant; 2007 Sep; 13(9):1106-15. PubMed ID: 17697973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictive factors for cytomegalovirus reactivation in cytomegalovirus-seropositive kidney-transplant patients.
    Kamar N; Mengelle C; Esposito L; Guitard J; Mehrenberger M; Lavayssière L; Ribes D; Cointault O; Durand D; Izopet J; Rostaing L
    J Med Virol; 2008 Jun; 80(6):1012-7. PubMed ID: 18428146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytomegalovirus replication and "herpesvirus burden" as risk factor of cardiovascular events in the first year after renal transplantation.
    Gómez E; Laurés A; Baltar JM; Melón S; Díez B; de Oña M
    Transplant Proc; 2005 Nov; 37(9):3760-3. PubMed ID: 16386530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A case report of CMV hepatitis and nephropathy after living related renal transplantation].
    Tanaka S; Fujioka M; Sasaki S
    Nihon Geka Gakkai Zasshi; 1993 Dec; 94(12):1305-8. PubMed ID: 8272070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human herpesvirus 6 infection of the gastroduodenal mucosa.
    Halme L; Arola J; Höckerstedt K; Lautenschlager I
    Clin Infect Dis; 2008 Feb; 46(3):434-9. PubMed ID: 18181741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sero-molecular evaluation of human cytomegalovirus disease in renal transplant rejection.
    Kishore J; Mukhopadhyay C; Savitri ; Ayyagari A; Sharma RK
    Nepal Med Coll J; 2004 Dec; 6(2):83-7. PubMed ID: 16295735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HLA-DQ3 is a probable risk factor for CMV infection in high-risk kidney transplant patients.
    Varga M; Rajczy K; Telkes G; Hídvégi M; Péter A; Remport A; Korbonits M; Fazakas J; Toronyi E; Sárváry E; Kóbori L; Járay J
    Nephrol Dial Transplant; 2008 Aug; 23(8):2673-8. PubMed ID: 18332066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does hepatitis C virus affect the reactivation of hepatitis B virus following renal transplantation?
    Yen TH; Huang CC; Lin HH; Huang JY; Tian YC; Yang CW; Wu MS; Fang JT; Yu CC; Chiang YJ; Chu SH
    Nephrol Dial Transplant; 2006 Apr; 21(4):1046-52. PubMed ID: 16390851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of the outcome of renal transplantation with antibody response to cytomegalovirus strain-specific glycoprotein H epitopes.
    Ishibashi K; Tokumoto T; Tanabe K; Shirakawa H; Hashimoto K; Kushida N; Yanagida T; Inoue N; Yamaguchi O; Toma H; Suzutani T
    Clin Infect Dis; 2007 Jul; 45(1):60-7. PubMed ID: 17554702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical manifestation, laboratory findings, and the response of treatment in kidney transplant recipients with CMV infection.
    Razeghi E; Hadadi A; Mansor-Kiaei M; Molavi M; Khashayar P; Pourmand G
    Transplant Proc; 2007 May; 39(4):993-6. PubMed ID: 17524872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Relation between cytomegalovirus infection and the so-called intolerance to azathioprine in renal transplantation].
    Ancona G; Dean P; Muolo A; Galvani E; Zanuso C; Gulino S; Confortini P
    Minerva Chir; 1980 May; 35(10):731-4. PubMed ID: 6256686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term renal graft function and survival in patients with high-risk for cytomegalovirus infection receiving preemptive therapy.
    Alberú J; Morales-Buenrostro LE; Correa-Rotter R; Muñoz-Trejo T; Zúñiga-Varga J; Cuéllar-González JV; Mayorga-Madrigal H; Vanegas-Carrero R; Aranda F; Rodríguez-Romo R; Herrera-Garcia C; González-Michaca L; Sierra-Madero JG
    Rev Invest Clin; 2008; 60(5):365-74. PubMed ID: 19227433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics of cutaneous cytomegalovirus infection in non-acquired immune deficiency syndrome, immunocompromised patients.
    Choi YL; Kim JA; Jang KT; Kim DS; Kim WS; Lee JH; Yang JM; Lee ES; Lee DY
    Br J Dermatol; 2006 Nov; 155(5):977-82. PubMed ID: 17034528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.